<?xml version="1.0" encoding="UTF-8"?>
<results title="tropicalVirus">
 <result pre="Group UKLondon pmcid: 691570713628 doi: 10.1038/s41467-019-13628-x : Article Impacts of" exact="Zika" post="emergence in Latin America on endemic dengue transmission BorcheringRebecca"/>
 <result pre="of this license, visit http://creativecommons.org/licenses/by/4.0/. Abstract In 2015 and 2016," exact="Zika" post="virus (ZIKV) swept through dengue virus (DENV) endemic areas"/>
 <result pre="incidence from Brazil and Colombia before, during, and after the" exact="Zika" post="epidemic. We find evidence that dengue incidence was atypically"/>
 <result pre="low in 2017 in both countries. We investigate whether subnational" exact="Zika" post="incidence is associated with changes in dengue incidence and"/>
 <result pre="mixed results. Using simulations with multiple assumptions of interactions between" exact="DENV" post="and ZIKV, we find cross-protection suppresses incidence of dengue"/>
 <result pre="and ZIKV, we find cross-protection suppresses incidence of dengue following" exact="Zika" post="outbreaks and low periods of dengue incidence are followed"/>
 <result pre="incidence are followed by resurgence. Our simulations suggest correlations in" exact="DENV" post="and ZIKV reproduction numbers could complicate associations between ZIKV"/>
 <result pre="followed by resurgence. Our simulations suggest correlations in DENV and" exact="ZIKV" post="reproduction numbers could complicate associations between ZIKV incidence and"/>
 <result pre="in DENV and ZIKV reproduction numbers could complicate associations between" exact="ZIKV" post="incidence and post-ZIKV DENV incidence and that periods of"/>
 <result pre="reproduction numbers could complicate associations between ZIKV incidence and post-ZIKV" exact="DENV" post="incidence and that periods of low dengue incidence are"/>
 <result pre="dengue incidence are followed by large increases in dengue incidence." exact="Dengue" post="and Zika virus are related flaviviruses, and introduction of"/>
 <result pre="are followed by large increases in dengue incidence. Dengue and" exact="Zika" post="virus are related flaviviruses, and introduction of Zika in"/>
 <result pre="Dengue and Zika virus are related flaviviruses, and introduction of" exact="Zika" post="in the Americas may have impacted dengue epidemiology. Here,"/>
 <result pre="and simulations incorporating immune-mediated interactions predict reductions in dengue following" exact="Zika" post="outbreaks with subsequent rebounds. Subject terms Computational biology and"/>
 <result pre="subsequent rebounds. Subject terms Computational biology and bioinformatics Ecological epidemiology" exact="Dengue" post="virus Infectious diseases Funding https://doi.org/10.13039/100000030U.S. Department of Health &amp;amp;"/>
 <result pre="Institutes of Health (NIH) R01AI102939LesslerJustin Introduction In 2015 and 2016," exact="Zika" post="virus (ZIKV) swept through many Latin American countries1 where"/>
 <result pre="epidemic, many locations appeared to experience abnormally low dengue incidence." exact="DENV" post="and ZIKV share a vector2,3 and are both flaviviruses."/>
 <result pre="locations appeared to experience abnormally low dengue incidence. DENV and" exact="ZIKV" post="share a vector2,3 and are both flaviviruses. Evidence suggests"/>
 <result pre="affect reported dengue cases. Conditions (climate16, vector abundance) that favor" exact="Zika" post="may be similar to those favoring dengue. Epidemics of"/>
 <result pre="the potential to disrupt the ecology of other circulating pathogens." exact="ZIKV" post="was identified in the Americas in Brazil in late"/>
 <result pre="Americas in Brazil in late 201517, though phylogeographic analyses suggest" exact="ZIKV" post="may have arrived as early as mid-201318, entering northeast"/>
 <result pre="63% (Salvador, Brazil22). These are comparable to seroprevalence in previous" exact="ZIKV" post="outbreaks; 73% in Yap Island, Micronesia23, 49% in French"/>
 <result pre="in Yap Island, Micronesia23, 49% in French Polynesia24. Associations between" exact="ZIKV" post="infection and severe disease outcomes such as microcephaly and"/>
 <result pre="March 20161, prompting intensified surveillance and control efforts. Since 2016," exact="Zika" post="incidence in Brazil has dropped precipitously, from over 200,000"/>
 <result pre="susceptible to infection. Multiple human and animal studies show that" exact="ZIKV" post="induces potently neutralizing antibody responses26,27, suggesting enduring ZIKV-specific immunity28."/>
 <result pre="potently neutralizing antibody responses26,27, suggesting enduring ZIKV-specific immunity28. The primary" exact="ZIKV" post="vectors, Aedes aegypti and Aedes albopictus2,3,29, also transmit chikungunya"/>
 <result pre="also transmit chikungunya virus (CHIKV) and DENV. In contrast to" exact="CHIKV" post="(an alphavirus), DENV and ZIKV are genetically similar flaviviruses8."/>
 <result pre="virus (CHIKV) and DENV. In contrast to CHIKV (an alphavirus)," exact="DENV" post="and ZIKV are genetically similar flaviviruses8. DENV exists as"/>
 <result pre="and DENV. In contrast to CHIKV (an alphavirus), DENV and" exact="ZIKV" post="are genetically similar flaviviruses8. DENV exists as four antigenically"/>
 <result pre="CHIKV (an alphavirus), DENV and ZIKV are genetically similar flaviviruses8." exact="DENV" post="exists as four antigenically distinct serotypes (DENV1-4). When an"/>
 <result pre="It has been speculated that, due to the similarity between" exact="DENV" post="and ZIKV, immunity to one of these viruses may"/>
 <result pre="periods, we do not find a negative association between cumulative" exact="Zika" post="incidence and biweekly dengue incidence in either country. To"/>
 <result pre="insight into how immunological interactions would impact the relationship between" exact="ZIKV" post="and DENV incidence in this period, we use a"/>
 <result pre="how immunological interactions would impact the relationship between ZIKV and" exact="DENV" post="incidence in this period, we use a stochastic compartmental"/>
 <result pre="period, we use a stochastic compartmental model of the four" exact="DENV" post="serotypes and ZIKV under multiple assumptions. In almost all"/>
 <result pre="a stochastic compartmental model of the four DENV serotypes and" exact="ZIKV" post="under multiple assumptions. In almost all simulations incorporating strong"/>
 <result pre="ZIKV under multiple assumptions. In almost all simulations incorporating strong" exact="ZIKV" post="cross-protection against subsequent DENV infection, ZIKV epidemics are followed"/>
 <result pre="In almost all simulations incorporating strong ZIKV cross-protection against subsequent" exact="DENV" post="infection, ZIKV epidemics are followed by a trough in"/>
 <result pre="all simulations incorporating strong ZIKV cross-protection against subsequent DENV infection," exact="ZIKV" post="epidemics are followed by a trough in dengue incidence,"/>
 <result pre="dengue incidence, followed by a larger than average peak in" exact="DENV" post="incidence. Correlated hazards of DENV and ZIKV transmission may"/>
 <result pre="larger than average peak in DENV incidence. Correlated hazards of" exact="DENV" post="and ZIKV transmission may complicate the relationship between ZIKV"/>
 <result pre="average peak in DENV incidence. Correlated hazards of DENV and" exact="ZIKV" post="transmission may complicate the relationship between ZIKV incidence and"/>
 <result pre="of DENV and ZIKV transmission may complicate the relationship between" exact="ZIKV" post="incidence and resulting dengue incidence. Our simulations consistently show"/>
 <result pre="from expected dengue incidence At the population level, the large" exact="ZIKV" post="epidemic could plausibly have led to either increases or"/>
 <result pre="dengue incidence in Brazil and Colombia (per 100,000). Note that" exact="Zika" post="incidence was not systematically reported prior to 2016 in"/>
 <result pre="Brazil (a) or late 2015 in Colombia (c) and that" exact="Chikungunya" post="was not systematically reported prior to 2015 and late"/>
 <result pre="For a baseline, we also fit models incorporating chikungunya incidence." exact="CHIKV" post="shares climate and vector determinants as DENV and ZIKV"/>
 <result pre="incorporating chikungunya incidence. CHIKV shares climate and vector determinants as" exact="DENV" post="and ZIKV but is of a different viral family"/>
 <result pre="incidence. CHIKV shares climate and vector determinants as DENV and" exact="ZIKV" post="but is of a different viral family and thus"/>
 <result pre="yellow. Shared effect coefficients for Brazil (a) and Colombia (c)." exact="Zika" post="and chikungunya coefficients are estimated from autoregressive dengue models."/>
 <result pre="year model and indirectly as effects on transmission for the" exact="Zika" post="and chikungunya models. Shared year multipliers for expected dengue"/>
 <result pre="gray. We found a positive association between the previous biweek’s" exact="Zika" post="incidence and dengue transmission potential in Brazil (mean coefficient:"/>
 <result pre="CrI: 0.05–0.26, Fig. 3a). Putting this coefficient in context, 1000" exact="Zika" post="cases observed in the previous biweek translates to a"/>
 <result pre="CrI: 1.40–6.15). We also found a positive association between cumulative" exact="Zika" post="incidence on dengue transmission potential in Brazil (mean coefficient:"/>
 <result pre="95% CrI: 0.003, 0.08). No significant associations were found between" exact="Zika" post="incidence and dengue transmission potential in Colombia. In Brazil,"/>
 <result pre="potential in Colombia. In Brazil, states with positive effects of" exact="Zika" post="on dengue transmission potential often observed positive effects of"/>
 <result pre="of chikungunya on dengue (Supplementary Fig. 7). Totals of suspected" exact="Zika" post="and suspected chikungunya cases at state- and department-level were"/>
 <result pre="Simulations incorporating immune-mediated interactions We tested whether immune-mediated interactions between" exact="DENV" post="and ZIKV could produce the dengue dynamics observed in"/>
 <result pre="immune-mediated interactions We tested whether immune-mediated interactions between DENV and" exact="ZIKV" post="could produce the dengue dynamics observed in Brazil and"/>
 <result pre="observed in Brazil and Colombia by simulating the arrival of" exact="Zika" post="in a dengue endemic population (Fig. 4 and Supplementary"/>
 <result pre="(see &quot;Methods�? for further details). We performed simulations in which" exact="ZIKV" post="was introduced to a population in which DENV was"/>
 <result pre="in which ZIKV was introduced to a population in which" exact="DENV" post="was in a stable state as well as simulations"/>
 <result pre="the sequential introduction of dengue over the decades preceding the" exact="ZIKV" post="introduction reflecting the observed detection of DENV serotypes37 (see"/>
 <result pre="decades preceding the ZIKV introduction reflecting the observed detection of" exact="DENV" post="serotypes37 (see Supplementary Fig. 12 for sample simulations from"/>
 <result pre="12 for sample simulations from both settings). In simulations where" exact="ZIKV" post="infection temporarily reduces an individual’s risk of DENV infection"/>
 <result pre="simulations where ZIKV infection temporarily reduces an individual’s risk of" exact="DENV" post="infection by 80%, Zika epidemics are followed by a"/>
 <result pre="temporarily reduces an individual’s risk of DENV infection by 80%," exact="Zika" post="epidemics are followed by a trough in dengue incidence"/>
 <result pre="Supplementary Table 1). Even in the absence of enhancement between" exact="DENV" post="and ZIKV, multiple simulations showed increases in dengue after"/>
 <result pre="assumed one-year duration of cross-protection. In all scenarios, suppression of" exact="DENV" post="transmission resulted in subsequent increases in DENV prevalence, suggesting"/>
 <result pre="scenarios, suppression of DENV transmission resulted in subsequent increases in" exact="DENV" post="prevalence, suggesting that the low period of incidence observed"/>
 <result pre="in DENV. Fig. 4 Simulation results incorporating immune-mediated interactions between" exact="DENV" post="and ZIKV. Mean and 95% inter-quantile range from stochastic"/>
 <result pre="ZIKV-introduction. 100 simulations per scenario (see &quot;Methods�? for further details)." exact="ZIKV" post="introduced after a 100 year burn-in period for four"/>
 <result pre="ZIKV introduced after a 100 year burn-in period for four" exact="DENV" post="serotypes (see Supplementary Fig. 11 for results when ZIKV"/>
 <result pre="four DENV serotypes (see Supplementary Fig. 11 for results when" exact="ZIKV" post="is introduced 40 years after DENV). DENV and ZIKV"/>
 <result pre="for results when ZIKV is introduced 40 years after DENV)." exact="DENV" post="and ZIKV reproduction numbers are assumed to be 4"/>
 <result pre="when ZIKV is introduced 40 years after DENV). DENV and" exact="ZIKV" post="reproduction numbers are assumed to be 4 and 2,"/>
 <result pre="which we use to define the start and end of" exact="DENV" post="prevalence troughs (see Methods and Supplementary Table 1). a–d"/>
 <result pre="a–d Individuals with previous dengue exposure experience 20% of the" exact="DENV" post="force of infection (FOI) that a fully susceptible person"/>
 <result pre="that a fully susceptible person would. e–h Individuals with previous" exact="ZIKV" post="exposure experience 80% of the FOI that a fully"/>
 <result pre="FOI that a fully susceptible person would. i–l Individuals with" exact="ZIKV" post="exposure experience 20% of the DENV FOI (same amount"/>
 <result pre="would. i–l Individuals with ZIKV exposure experience 20% of the" exact="DENV" post="FOI (same amount of cross-protection between dengue and Zika"/>
 <result pre="the DENV FOI (same amount of cross-protection between dengue and" exact="Zika" post="than between dengue serotypes). We also tested the impact"/>
 <result pre="dengue serotypes). We also tested the impact of correlation in" exact="ZIKV" post="and DENV transmission intensity on observed associations between cumulative"/>
 <result pre="We also tested the impact of correlation in ZIKV and" exact="DENV" post="transmission intensity on observed associations between cumulative ZIKV and"/>
 <result pre="ZIKV and DENV transmission intensity on observed associations between cumulative" exact="ZIKV" post="and DENV incidence (see Supplementary Fig. 10). We consistently"/>
 <result pre="DENV transmission intensity on observed associations between cumulative ZIKV and" exact="DENV" post="incidence (see Supplementary Fig. 10). We consistently observed a"/>
 <result pre="Supplementary Fig. 10). We consistently observed a reduced impact of" exact="ZIKV" post="on dengue in simulations where DENV transmissibility was assumed"/>
 <result pre="a reduced impact of ZIKV on dengue in simulations where" exact="DENV" post="transmissibility was assumed to be higher. When the transmissibility"/>
 <result pre="transmissibility was assumed to be higher. When the transmissibility of" exact="ZIKV" post="and DENV were assumed to be equal, reductions in"/>
 <result pre="assumed to be higher. When the transmissibility of ZIKV and" exact="DENV" post="were assumed to be equal, reductions in DENV due"/>
 <result pre="ZIKV and DENV were assumed to be equal, reductions in" exact="DENV" post="due to cross protection were not larger in simulations"/>
 <result pre="to cross protection were not larger in simulations with higher" exact="ZIKV" post="attack rates as the impact of ZIKV was offset"/>
 <result pre="simulations with higher ZIKV attack rates as the impact of" exact="ZIKV" post="was offset by increased DENV transmissibility. These results are"/>
 <result pre="rates as the impact of ZIKV was offset by increased" exact="DENV" post="transmissibility. These results are consistent with an unclear or"/>
 <result pre="results are consistent with an unclear or variable relationship between" exact="DENV" post="reductions and cumulative ZIKV incidence as we have observed"/>
 <result pre="an unclear or variable relationship between DENV reductions and cumulative" exact="ZIKV" post="incidence as we have observed in the data. Discussion"/>
 <result pre="reduction in dengue incidence in Brazil and Colombia. Utilizing available" exact="Zika" post="case data, we were unable to establish a direct"/>
 <result pre="to establish a direct link between this reduction and the" exact="Zika" post="epidemic. It is important to note that there are"/>
 <result pre="particularly when novel pathogens are involved. In the case of" exact="ZIKV" post="invasion in the Americas, many cases that occurred early"/>
 <result pre="since it took time to first identify the presence of" exact="ZIKV" post="and then to establish reporting protocols. The unavailability of"/>
 <result pre="ZIKV and then to establish reporting protocols. The unavailability of" exact="Zika" post="case count data during the height of the ZIKV"/>
 <result pre="of Zika case count data during the height of the" exact="ZIKV" post="epidemic in northeast Brazil, one of the most severely"/>
 <result pre="contributed to our inability to identify a relationship between cumulative" exact="Zika" post="cases and observed dengue incidence. In both Brazil and"/>
 <result pre="both confirmed and unconfirmed cases) in all of our analyses." exact="Zika" post="and chikungunya case counts were first reported in the"/>
 <result pre="most comparable to the preceding historical data. Analogous updated probable" exact="Zika" post="and chikungunya case counts were first reported in 2017"/>
 <result pre="they were reported separately. We extracted additional data for probable" exact="Zika" post="and chikungunya cases from the weekly Epidemiological Bulletins36 for"/>
 <result pre="Colombia’s Directorate of Surveillance and Risk Analysis in Public Health," exact="Zika" post="has been in the country since 2015 Epiweek 40"/>
 <result pre="1 bulletin. In the updated Colombia dataset, the first documented" exact="Zika" post="cases were in 2015 Epiweek 25. Case counts in"/>
 <result pre="years (2015, 2016, 2017) or a multiplicative effect of either" exact="Zika" post="or chikungunya case counts (previous biweek or total count"/>
 <result pre="offset for year-specific subnational population size (Ni,t). Xi,t represents either:" exact="Zika" post="or chikungunya incidence (either at biweek t or the"/>
 <result pre="overlap zero. Stochastic compartmental model We developed a four serotype" exact="DENV" post="model that also allowed for ZIKV infection in both"/>
 <result pre="developed a four serotype DENV model that also allowed for" exact="ZIKV" post="infection in both mosquito and human populations. There are"/>
 <result pre="infected with ZIKV. The human compartments are based on both" exact="DENV" post="and ZIKV status. With respect to DENV infection status,"/>
 <result pre="ZIKV. The human compartments are based on both DENV and" exact="ZIKV" post="status. With respect to DENV infection status, individuals in"/>
 <result pre="based on both DENV and ZIKV status. With respect to" exact="DENV" post="infection status, individuals in the human population are either"/>
 <result pre="cross-protected, or recovered. We keep track of primary and secondary" exact="DENV" post="infections and assume that after two heterotypic DENV infections,"/>
 <result pre="and secondary DENV infections and assume that after two heterotypic" exact="DENV" post="infections, individuals become immune to further DENV infections. Homotypic"/>
 <result pre="after two heterotypic DENV infections, individuals become immune to further" exact="DENV" post="infections. Homotypic reinfections are not allowed in the model."/>
 <result pre="The human classes are further stratified depending on the individual’s" exact="ZIKV" post="status: either susceptible, infectious, cross-protected (from DENV), or recovered."/>
 <result pre="or cross-protection. The enhancement scenarios we considered included: no enhancement," exact="DENV" post="enhances DENV, DENV enhances DENV and ZIKV, and enhancement"/>
 <result pre="enhancement scenarios we considered included: no enhancement, DENV enhances DENV," exact="DENV" post="enhances DENV and ZIKV, and enhancement in all directions."/>
 <result pre="we considered included: no enhancement, DENV enhances DENV, DENV enhances" exact="DENV" post="and ZIKV, and enhancement in all directions. Enhancement was"/>
 <result pre="a dengue infection would reduce the hazard of a future" exact="Zika" post="infection and a Zika infection would reduce the hazard"/>
 <result pre="reduce the hazard of a future Zika infection and a" exact="Zika" post="infection would reduce the hazard of a future dengue"/>
 <result pre="dengue infection. Cross-serotype dengue protection (80% hazard reduction to other" exact="DENV" post="serotypes) was included in all scenarios. The average duration"/>
 <result pre="included in all scenarios. The average duration of cross-protection between" exact="DENV" post="serotypes was one year (γ = 1)46. We considered the case"/>
 <result pre="(γ = 1)46. We considered the case when cross-protection between dengue and" exact="Zika" post="also lasted one year on average. The scenarios without"/>
 <result pre="4 days (γ = 1/100). We considered two levels of cross-protection between" exact="DENV" post="and ZIKV. The high-level matched the level of cross-serotype"/>
 <result pre="only 20% (�? = 0.8). We did not incorporate seasonality in either" exact="DENV" post="or ZIKV transmission but expect simulations with seasonality to"/>
 <result pre="(�? = 0.8). We did not incorporate seasonality in either DENV or" exact="ZIKV" post="transmission but expect simulations with seasonality to be qualitatively"/>
 <result pre="using a tau-leap approximation of the Gillespie method in Fortran." exact="ZIKV" post="was introduced into the mosquito population after 100 years"/>
 <result pre="was introduced into the mosquito population after 100 years of" exact="DENV" post="only simulations. Numerical solutions for the corresponding deterministic system"/>
 <result pre="data was simulated after the introduction of ZIKV. We considered" exact="DENV" post="and ZIKV reproduction numbers for all combinations of 2"/>
 <result pre="simulated after the introduction of ZIKV. We considered DENV and" exact="ZIKV" post="reproduction numbers for all combinations of 2 and 4"/>
 <result pre="2 and 4 (see Fig. 4 for the case when" exact="DENV" post="and ZIKV reproduction numbers are 4 and 2 respectively),"/>
 <result pre="4 (see Fig. 4 for the case when DENV and" exact="ZIKV" post="reproduction numbers are 4 and 2 respectively), and for"/>
 <result pre="was performed in R. We also considered the case when" exact="ZIKV" post="was introduced after 40 years of DENV only simulations"/>
 <result pre="the case when ZIKV was introduced after 40 years of" exact="DENV" post="only simulations (see Supplementary Figs. 11 and 12). For"/>
 <result pre="are introduced each year for each serotype. Sample simulations displaying" exact="DENV" post="dynamics prior to the introduction of ZIKV under both"/>
 <result pre="Sample simulations displaying DENV dynamics prior to the introduction of" exact="ZIKV" post="under both stable and recently introduced DENV conditions are"/>
 <result pre="the introduction of ZIKV under both stable and recently introduced" exact="DENV" post="conditions are displayed in Supplementary Fig. 12. To evaluate"/>
 <result pre="by the scenario with no enhancement and no cross-protection between" exact="DENV" post="and ZIKV (see Fig. 4a). We define the trough"/>
 <result pre="scenario with no enhancement and no cross-protection between DENV and" exact="ZIKV" post="(see Fig. 4a). We define the trough duration to"/>
 <result pre="trough duration to be the length of time that aggregated" exact="DENV" post="prevalence is consecutively less than one half of the"/>
 <result pre="of ZIKV. Peak size is defined to be the maximum" exact="DENV" post="prevalence value, aggregated across all serotypes, in the 20"/>
 <result pre="ZIKV. Changes in peak size resulting from incorporating cross-protection between" exact="DENV" post="and ZIKV were evaluated by dividing the average peak"/>
 <result pre="in peak size resulting from incorporating cross-protection between DENV and" exact="ZIKV" post="were evaluated by dividing the average peak size for"/>
 <result pre="Report-Zika virus, microcephaly and Guillain-Barré syndrome. http://origin.searo.who.int/entity/bhutan/who-zika-28-7-16.pdf. (2016). 2.AyresCFJIdentification of" exact="Zika" post="virus vectors and implications for controlLancet Infect. Dis.20161627827910.1016/S1473-3099(16)00073-626852727 3.Chouin-Carneiro,"/>
 <result pre="(ed. Shields, V. D. C.) (InTech, 2017). 4.BardinaSVet al.Enhancement of" exact="Zika" post="virus pathogenesis by preexisting antiflavivirus immunityScience201735617518010.1126/science.aal436528360135 5.DejnirattisaiWet al.Dengue virus"/>
 <result pre="5.DejnirattisaiWet al.Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with" exact="Zika" post="virusNat. Immunol.2016171102110810.1038/ni.351527339099 6.PaulLMet al.Dengue virus antibodies enhance Zika virus"/>
 <result pre="infection with Zika virusNat. Immunol.2016171102110810.1038/ni.351527339099 6.PaulLMet al.Dengue virus antibodies enhance" exact="Zika" post="virus infectionClin. Transl. Immunol.20165e11710.1038/cti.2016.72 7.StettlerKet al.Specificity, cross-reactivity, and function"/>
 <result pre="Immunol.20165e11710.1038/cti.2016.72 7.StettlerKet al.Specificity, cross-reactivity, and function of antibodies elicited by" exact="Zika" post="virus infectionScience201635382382610.1126/science.aaf850527417494 8.Barba-SpaethGet al.Structural basis of potent Zika–dengue virus"/>
 <result pre="potent Zika–dengue virus antibody cross-neutralizationNature20165364810.1038/nature1893827338953 9.Swanstrom, J. A. et al." exact="Dengue" post="virus envelope dimer epitope monoclonal antibodies isolated from dengue"/>
 <result pre="epitope monoclonal antibodies isolated from dengue patients are protective against" exact="Zika" post="virus. MBio7, e01123-16 (2016). 10.Rodriguez-BarraquerIet al.Impact of preexisting dengue"/>
 <result pre="MBio7, e01123-16 (2016). 10.Rodriguez-BarraquerIet al.Impact of preexisting dengue immunity on" exact="Zika" post="virus emergence in a dengue endemic regionScience201936360761010.1126/science.aav661830733412 11.Badolato-CorrêaJet al.Human"/>
 <result pre="a dengue endemic regionScience201936360761010.1126/science.aav661830733412 11.Badolato-CorrêaJet al.Human T cell responses to" exact="Dengue" post="and Zika virus infection compared to Dengue/Zika coinfectionImmun. Inflamm."/>
 <result pre="endemic regionScience201936360761010.1126/science.aav661830733412 11.Badolato-CorrêaJet al.Human T cell responses to Dengue and" exact="Zika" post="virus infection compared to Dengue/Zika coinfectionImmun. Inflamm. Dis.2018619420610.1002/iid3.20329282904 12.VogelsCBFet"/>
 <result pre="co-transmission: a neglected public health concern?PLoS Biol.201917e300013010.1371/journal.pbio.300013030668574 13.ChavesBAet al.Coinfection with" exact="Zika" post="virus (ZIKV) and Dengue virus results in preferential ZIKV"/>
 <result pre="health concern?PLoS Biol.201917e300013010.1371/journal.pbio.300013030668574 13.ChavesBAet al.Coinfection with Zika virus (ZIKV) and" exact="Dengue" post="virus results in preferential ZIKV transmission by vector bite"/>
 <result pre="with Zika virus (ZIKV) and Dengue virus results in preferential" exact="ZIKV" post="transmission by vector bite to vertebrate hostJ. Infect. Dis.201821856357110.1093/infdis/jiy19629659904"/>
 <result pre="in BrazilLancet20163871052105310.1016/S0140-6736(16)00626-726944024 16.CaminadeCet al.Global risk model for vector-borne transmission of" exact="Zika" post="virus reveals the role of El Niño 2015Proc. Natl"/>
 <result pre="DataPLoS Negl. Trop. Dis.201610e000468710.1371/journal.pntd.000468727111294 19.FariaNRet al.Establishment and cryptic transmission of" exact="Zika" post="virus in Brazil and the AmericasNature201754640641010.1038/nature2240128538727 20.World Health Organization."/>
 <result pre="http://apps.who.int/iris/bitstream/10665/254714/1/zikasitrep10Mar17-eng.pdf?ua=1 (2017). 21.ZambranaJVet al.Seroprevalence, risk factor, and spatial analyses of" exact="Zika" post="virus infection after the 2016 epidemic in Managua, NicaraguaProc."/>
 <result pre="Natl Acad. Sci. USA20181159294929910.1073/pnas.180467211530150394 22.Netto, E. M. et al. High" exact="Zika" post="Virus Seroprevalence in Salvador, Northeastern Brazil limits the potential"/>
 <result pre="Repository, 10.5281/zenodo.2566509 (2019). 26.RobbianiDFet al.Recurrent potent human neutralizing antibodies to" exact="Zika" post="virus in Brazil and MexicoCell2017169597609.e1110.1016/j.cell.2017.04.02428475892 27.SapparapuGet al.Neutralizing human antibodies"/>
 <result pre="virus in Brazil and MexicoCell2017169597609.e1110.1016/j.cell.2017.04.02428475892 27.SapparapuGet al.Neutralizing human antibodies prevent" exact="Zika" post="virus replication and fetal disease in miceNature201654044344710.1038/nature2056427819683 28.MontoyaMet al.Longitudinal"/>
 <result pre="disease in miceNature201654044344710.1038/nature2056427819683 28.MontoyaMet al.Longitudinal analysis of antibody cross-neutralization following" exact="Zika" post="virus and Dengue virus infection in Asia and the"/>
 <result pre="28.MontoyaMet al.Longitudinal analysis of antibody cross-neutralization following Zika virus and" exact="Dengue" post="virus infection in Asia and the AmericasJ. Infect. Dis.201821853654510.1093/infdis/jiy16429618091"/>
 <result pre="American countries as a crucial factor in the spread of" exact="Chikungunya" post="virusJ. Virol.2014886294630610.1128/JVI.00370-1424672026 30.SabinABResearch on dengue during World War II1Am."/>
 <result pre="control of dengue virus infectionNat. Rev. Immunol.20151574575910.1038/nri391626603900 32.Halstead, S. B." exact="Dengue" post="antibody-dependent enhancement: knowns and unknowns. Microbiol. Spectr.2, 249–271 (2014)."/>
 <result pre="casos de dengue, febre de chikungunya e febre pelo vírus" exact="Zika" post="até a Semana Epidemiológica 52, 2015. Boletim Epidemiológico. http://portalms.saude.gov.br/boletins-epidemiologicos#."/>
 <result pre="mapping the 70 year historyTrends Microbiol.20142213814610.1016/j.tim.2013.12.01124468533 38.RibeiroGSet al.Does immunity after" exact="Zika" post="virus infection cross-protect against dengue? LancetGlob. Health20186e140e141 39.Pan American"/>
 <result pre="Health Information Platform for the Americas (PLISA). Reported Cases of" exact="Dengue" post="Fever in The Americas. http://www.paho.org/data/index.php/en/mnu-topics/indicadores-dengue-en/dengue-nacional-en/252-dengue-pais-ano-en.html. 40.Ministerio da Saude Brasil."/>
</results>
